House and Senate lawmakers are urging Congress to quickly re-up a program that speeds up drug and device approval times at the Food and Drug Administration.

House and Senate committee leaders introduced draft legislation to reauthorize the user fee program for the FDA, which needs to be renewed before the August recess. The reauthorization legislation comes at a time when the White House wants more of the agency funding to come from user fees and less from the federal government.